Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik-Oliver Glocker

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Digestion|September 16, 2015
The Need for Resistance Surveillance and Antimicrobial Susceptibility Testing of Helicobacter pyloriErik-Oliver Glocker
Immunology and Cell Biology|May 18, 2011
Mucosal antifungal defence: IL-17 signalling takes centre stageErik-Oliver Glocker, Bodo Grimbacher
Current Allergy and Asthma Reports|August 15, 2012
Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel diseaseNeil Shah, Jochen Kammermeier, Mamoun Elawad, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2015
Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testingSarah Draeger, Nicole Wüppenhorst, Manfred Kist, et al.
Helicobacter|June 7, 2018
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testingBenjamin Blümel, Hanna Goelz, Manfred Kist, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2013
High secondary resistance to quinolones in German Helicobacter pylori clinical isolatesNicole Wueppenhorst, Hans-Peter Stueger, Manfred Kist, et al.
Annals of the New York Academy of Sciences|January 13, 2012
IL-10 and IL-10 receptor defects in humansErik-Oliver Glocker, Daniel Kotlarz, Christoph Klein, et al.
Lancet (London, England)|October 12, 2010
Infant colitis--it's in the genesErik-Oliver Glocker, Natalie Frede, Mario Perro, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in GermanyNicole Wüppenhorst, Sarah Draeger, Hans Peter Stüger, et al.
BMC Immunology|March 4, 2014
Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel diseaseNatalie Frede, Erik-Oliver Glocker, Jennifer Wanders, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Digestion|September 16, 2015
The Need for Resistance Surveillance and Antimicrobial Susceptibility Testing of Helicobacter pyloriErik-Oliver Glocker
Immunology and Cell Biology|May 18, 2011
Mucosal antifungal defence: IL-17 signalling takes centre stageErik-Oliver Glocker, Bodo Grimbacher
Current Allergy and Asthma Reports|August 15, 2012
Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel diseaseNeil Shah, Jochen Kammermeier, Mamoun Elawad, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2015
Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testingSarah Draeger, Nicole Wüppenhorst, Manfred Kist, et al.
Helicobacter|June 7, 2018
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testingBenjamin Blümel, Hanna Goelz, Manfred Kist, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2013
High secondary resistance to quinolones in German Helicobacter pylori clinical isolatesNicole Wueppenhorst, Hans-Peter Stueger, Manfred Kist, et al.
Annals of the New York Academy of Sciences|January 13, 2012
IL-10 and IL-10 receptor defects in humansErik-Oliver Glocker, Daniel Kotlarz, Christoph Klein, et al.
Lancet (London, England)|October 12, 2010
Infant colitis--it's in the genesErik-Oliver Glocker, Natalie Frede, Mario Perro, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in GermanyNicole Wüppenhorst, Sarah Draeger, Hans Peter Stüger, et al.
BMC Immunology|March 4, 2014
Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel diseaseNatalie Frede, Erik-Oliver Glocker, Jennifer Wanders, et al.
Pageof 2